Cetforlimumab

From Wikipedia, the free encyclopedia

This article or section does not adequately cite its references or sources.
Please help improve this article by adding citations to reliable sources. (help, get involved!)
Any material not supported by sources may be challenged and removed at any time. This article has been tagged since April 2007.
Cetforlimumab
Therapeutic monoclonal antibody
Source Human
Target  ?
Identifiers
CAS number  ?
ATC code  ?
Chemical data
Formula  ?
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?
Legal status
Routes  ?

Cetforlimumab is a human monoclonal antibody which it's used to treat cancer.

v • d • e
Human monoclonal antibodies

Adalimumab, Adecatumumab, Anetumumab, Atorolimumab, Belimumab, Bertilimumab, Betumumab, Cetforlimumab, Cetinlimumab, Cetlalimumab, Cetolimumab, Cynosumab, Denosumab, Duntumumab, Durimulumab, Durmulumab, Efungumab, Exbivirumab, Futumumab, Genosumab, Golimumab, Intumumab, Ipilimumab, Iratumumab, Lerdelimumab, Lexatumumab, Libivirumab, Mapatumumab, Metelimumab, Nebacumab, Ofatumumab, Panitumumab, Pritumumab, Raxibacumab, Regavirumab, Resatumumab, Restumumab, Rosutumumab, Sevirumab, Stamulumab, Synosumab, Ticilimumab, Tritumumab, Trixatumumab, Tuvirumab, Vexatumumab, Votumumab, Zalutumumab, Zanolimumab, Ziralimumab


Pills  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../c/e/t/Cetforlimumab.html"